A Bispecific γδ T-cell Engager Targeting EGFR Activates a Potent Vγ9Vδ2 T cell–Mediated Immune Response against EGFR-Expressing TumorsLisa A. King, Hans van Vliet|Cancer Immunology Research|2023Cited by 35